Metachronous, Multicentric Giant Cell Tumor of the Sphenoid Bone with Histologic, CT, MR Imaging, and Positron-Emission Tomography/CT Correlation

References

1. ↵
   Hindman BW, Seeger LL, Stanley P, et al. Multicentric giant cell tumor: report of five new cases. Skeletal Radiol 1994;23:187–90

   PubMed
2. ↵
   Sim FH, Dahlin DC, Beabout JW. Multicentric giant cell tumor of bone. J Bone Joint Surg 1977;59A:1052–60

   PubMed
3. ↵
   Yamamoto M, Fukushima T, Sakamoto S, et al. Giant cell tumor of the sphenoid bone: long-term follow-up of two cases after chemotherapy. Surg Neurol 1998;49:547–52

   CrossRefPubMedWeb of Science
4. ↵
   Rimmelin A, Roth T, George B, et al. Giant-cell tumour of the sphenoid bone: case report. Neuroradiology 1996;38:650–53

   CrossRefPubMed
5. ↵
   Kishima H, Miyao Y, Shimizu K. Radiosensitive giant cell tumour of the sphenoid bone. Br J Neurosurg 2001;15:171–74

   PubMed
6. ↵
   Strauss LG, Dimitrakopoulou-Strauss A, Koczan D, et al. 18F-FDG kinetics and gene expression in giant cell tumors. J Nucl Med 2004;45:1528–35

   Abstract/FREE Full Text
7. ↵
   Yanagawa T, Watanabe H, Inoue T, et al. Carbon-11 choline positron emission tomography in musculoskeletal tumors: comparison with fluorine-18 fluorodeoxyglucose positron emission tomography. J Comput Assist Tomogr 2003;27:175–82

   CrossRefPubMed
8. ↵
   Delbeke D, Martin WH, Patton JH, et al, eds. Practical FDG Imaging. New York: Springer-Verlag;2002
9. ↵
   Allal AS, Slosman DO, Kebdani T, et al. Prediction of outcome in head-and-neck cancer patients using the standardized Uptake value of 2-[18F]fluoro-2-deoxy-D-glucose. Int J Radiat Oncol Biol Phys 2004;59:1295–300

   PubMedWeb of Science